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Corynebacterium parvum (C. parvum)
can cause a significant reduction in the
growth ofboth primary tumours and their
metastases (Sadler and Castro, 1976;
Proctor, Rudenstam and Alexander, 1973;
Woodruff and Boak, 1966).
When consideration is given to the
effects of systemic C. parvum on primary
tumours there is evidence that T cells
are notrequired for its antitumour activity
(Woodruff, Dunbar and Ghaffar, 1973)
and that macrophages are the effector
cells (Olivotto and Bomford, 1974;
Ghaffar, Cullen and Woodruff, 1975).
This is supported by the observations
that C. parvum inhibits the growth of
solid, subcutaneous (s.c.) tumour in both
normal and T-cell-deprived mice (thy-
mectomized, lethally irradiated and bone-
marrow-reconstituted) (Davies et al.,
1966). Furthermore, macrophages from
either normal, thymectomized or nude
mice, if they have been treated with
C. parvum, are cytotoxic for tumour cells
in vitro. In contrast, the antitumour
activity of C. parvum injected directly
into the primary tumour does appear to
be dependent on T cells, as this effect is
abrogated in T-cell-deprived mice (Scott,
1974; Woodruff and Dunbar, 1975).
The mechanism of action of C. parvum
on tumour metastases may be different
from that involved in the destruction of
primary tumours, for there is evidence
that host immunological responses can
deal more effectively with disseminated
tumour foci than with a single tumour
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mass (Carnaud, Hoch and Trainin, 1974).
Indeed, C. parvum has a more inhibitory
effect on the growth of metastases than
on the primary tumour (Sadler and Castro,
1976).
Inthe present studythe antimetastatic
action of C. parvum was investigated by
observing its effects on metastases from
the Lewis lung carcinoma in normal mice
and mice made T-cell deficient either by
thymectomy and irradiation or by treat-
ment with antilymphocyte serum
(ALS).
Age-matched syngeneic female C57/BL
mice (Olac) were used. Lewis lung car-
cinoma, which originated spontaneously
as a carcinoma of the lung of a C57/BL
mouse at the Wistar Institute in 1951
(Sugiura and Stock, 1955) was implanted
s.c. as a 0-1-ml homogenate in the lower
flank. It is a rapidly growing epidermoid
carcinoma which, when implanted s.c.,
metastasizes to the lung (Simpson-Herren,
Sanford and Holmquist, 1974). Cells are
released from the primary tumour 6 days
after implantation (James and Salsbury,
1974). Macroscopic lung metastases were
counted 21 days after tumour implanta-
tion, after staining the lungs by inflation
with indian ink (Wexler, 1966).
C. parvum (Burroughs Wellcome,
CN 6134, Batch PX416, 7 mg dry wt./ml)
was injected i.v. at a dose of 0-466 mg in
0*2 ml normal saline. Control mice re-
ceived the same volume of normal saline.
Adult thymectomy was by a method
previously described (Castro, 1974).T. E. SADLER AND J. E. CASTRO
After 10 days, mice received 450 rad
sublethal irradiation and 4 weeks later
they were inoculated with tumour. Num-
bers of metastases were compared in both
thymectomized/irradiated and control
mice, with and without C. parvum.
Statistical analysis was by Student's t
test.
Mice received s.c. antilymphocyte
serum (ALS) (Searle Diagnostics Limited,
Batch 10-made by a standard 2-pulse
inoculation schedule of thymocytes into
rabbits) in a dose of 0-25 ml on Days 2, 1
and 0 before the tumour and then weekly.
Control mice received normal rabbit
serum -(NRS). The ALS used in this
study was found to increase the mean
survival time (MST) of Balb C tail skin
allografts on C57/BL recipient mice from
13 to 19 days. Metastases were compared
in both ALS-treated and control mice
with and without C. parvum.
For cytoxic tests a cell suspension of
the Lewis tumour was made, using the
technique described by Courtenay (1976).
Finely chopped tumour was rinsed twice
in PBS (Dulbecco A) and trypsinized in
0.25% trypsin (Bactotrypsin Difco diluted
-'1) in PBS (up to 0 5 g tumour in 10 ml)
at 370C for 10 min. The tumour was
agitated and allowed to settle. The
supernatant was then removed and
trypsinization repeated, incubating for
10-20 min. The supernatant was again
discarded and the tumour resuspended in
Ham's F12 medium (Biocult) and incu-
bated for 5-10 min. The tube was given
3-4 sharp shakes and the resulting cell
suspension pipetted into a tube containing
foetal calf serum (FCS) (Biocult) to give
a 10% concentration. The cells were
centrifuged at 350g for 10 min and
resuspended in fresh medium containing
20% FCS and finally filtered through a
stainless steel sieve. Viability was more
than 90%.
The toxicity of ALS for tumour cells
wab determined using the cytotoxic assay
described by Boyle, Ohanian and Borsos
(1976). The test was done using micro
test tubes (Eppendorf) containing 105
Lewis tumour cells, suspended in 0-1 ml
Ham's F12 medium with 20% FCS.
Prepared tubes were incubated with an
equal volume of serum for 30 min at
30°C. The serum was from normal mice
which had received s.c. ALS or NRS on
Days -2, -1, 0 and + 7, taken at 2 h,
24 h or 4 days after the last s.c. injection,
or from untreated mice. Appropriate
positive and negative controls were in-
cluded in the test. The tubes were
centrifuged at 350g for 10 min, the
supernatant discarded and the cells re-
suspended in 0-1 ml medium containing
FOS. They were then incubated for 1 h
at 37TC in the presence of 0'1 ml of a
1: 8 dilution guinea-pig complement (Well-
come). The cells were then mixed with
Trypan blue and the number of cells
taking up the dye was assessed by visual
counting in a haemocytometer.
The phagocytic index, K, in tumour-
bearing mice treated with ALS or NRS,
and C. parvum was measured by clearance
of colloidal carbon from the blood, using a
modification of the technique described
by Biozzi et al. (1954). Mice were bled
from the retro-orbital plexus at 2, 5, 10,
15 and 20 min after an i.v. injection of
colloidal carbon (14.5% Pelican ink,
1% gelatin in water given at 0.01 ml/g
body wt) using 0*02-ml Benjamin
heparinized haematocrit tubes. The
blood was lysed in 2 ml of water and the
optical density D determined in a Unicam
colorimeter with a 650-mm red filter.
K was calculated for each mouse by the
method of least squares, as a regression
coefficient multipliedby-1, ofthestraight
line relating to the logarithms of the D
reading plotted against time. A com-
bined estimate of K and standard error
was determined for each group.
C. parvumgreatly inhibitedthenumber
of metastases occurring in normal mice
(Tables I and II). There was an
equivalent number of metastases in the
thymectomized as in normal mice and
this number was significantly reduced
after C. parvum (Table I). ALS-treated
mice had significantly fewer metastases
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TABLE I.-Effect of Thymectomy (Tx) and
Irradiation on the Action of C. parvum
on Metastases from the Lewis Lung
Tumour
Treatment
1. Tumour
2. Tumour + C.p.
3. Tx + irrad. + tumour
4. Tx + irrad. + tumour
+ C.p.
No. of
mice
17
20
16
Mean
metastases
+ s.d.
41-5+14-6
8-5+ 5.0
50-0+23-0
18 14-0+11*0
TABLE III.-Cytotoxicity of Serum from
Non-tumour-bearing Mice against Lewis
Lung Tumour Cells. Serum was Taken
at Intervals after the Last Injection of
ALS or NRS (see text)
Time after last
injection of
ALS or NRS
NRS
ALS
None
Mean % cells killed
r A
2 h 24 h 4 days
8-0 8-0 10 0
9-0 11.0 10-0
6-5 15-5 9 0
Significance bv Student's t test
2v81 P<0001
3v8 1 P<0*9
4vs3 P<0001
TABLE II.-The effect of NRS or ALS on
the Action of C. parvum on Metastases
from the Lewis Lung Tumour
Treatment
1. NRS + tumour
2. NRS + C.p. + tumour
3. ALS + tumour
4. ALS + C.p. + tumour
Mean
No. of metastases
mice + s.d.
14 34-0+6-3
15 4-0+3-1
13 23-5+8-7
13 21-0+6-7
The figures are the combined results from 2 separate
experiments
Significance by Student's t test
2vs1 P<0.001
3v8I P<0O001
4vs3 P<0 4
than those given NRS, and this number
was not further decreased after C. parvum
(Table II).
The cytotoxity of sera from normal
mice which had received the same regime
of NRS and ALS as the tumour-bearing
mice (i.e., s.c. injections on Days -2,
-1, 0 and + 7) was studied. Serum
was taken by cardiac puncture at 2 h,
24 h and 4 days after the last injection,
on Day 7. The results are shown in
Table III. Sera from both NRS- and
ALS-treated mice were not cytotoxic.
The phagocytic index, K, for tumour-
bearing mice treated with NRS or ALS,
and C. parvum was determined 8 days
after tumour implantation (Table IV).
C. parvum increased the K in both NRS-
and ALS-treated mice. There was no
significant differences between mice re-
ceiving NRS or ALS.
TABLE IV.-Effect of NRS or ALS and
C. parvum on the Phagocytic Index of
Tumour-bearing Mice
Phagocytic index
Treatment No. ofmice + s.e. mean
NRS + tumour
NRS + C.p. + tumour
ALS + tumour
ALS + C.p. + tumour
3
2
3
3
0-0661+ 0-0074
0-1078+ 0-0042
0 0764+0-0025
0 0945+0 0034
The antimetastatic action ofC. parvum
was investigated using the Lewis lung
carcinoma, a tumour which when grown
s.c. metastasizes naturally to the lungs
(Simpson-Herren et al., 1974). Reported
experiments using primary tumour have
indicated that T cell involvement in the
anti-tumour response to C. parvum de-
pends upon the route of injection of this
vaccine (Woodruff et al., 1973; Scott,
1974; Woodruff and Dunbar, 1975). The
importance of T cells in the response of
the host against metastases after C.
parvum injection was investigated by
depleting mice of these cells by thy-
mectomy and irradiation, or by treatment
withALS.
When compared with controls there
was no significant change in the numbers
ofmetastases in thymectomized irradiated
mice. In such mice the antimetastatic
effectsofC.parvumwereunchanged. These
findings may be comparable with the
results obtained by Woodruff and Dunbar
(1975) and Scott (1974) on solid tumours
in T-cell-deficient mice. However, the
depletion of T cells in our experiments
was less than in their thymectomized,
lethally irradiated and reconstituted mice.
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There was a significant reduction in
the number of metastases in ALS-treated
mice when compared with those given
NRS. This inhibition could be explained
if ALS was directly cytotoxic for tumour
cells. However, sera taken from ALS-
treated normal mice at a time in the
schedule ofALS injection when malignant
cells would be inthe circulation oftumour-
bearing mice (James and Salsbury, 1974),
was found not to be cytotoxic for Lewis
tumour cells.
Another explanation for the reduction
in number of metastases after ALS
treatment could be that a specific sub-
population of T cells is required for the
optimal growth of these metastases. In-
deed, tumour-enhancing T lymphocytes
have been reported in the Lewis lung
system (Treves et al., 1974); Umiel and
Trainin, 1974). The observation that
thymectomy and irradiation did not
inhibit metastases, whereas ALS caused
their reduction, might be explained if
these 2 procedures affect different sub-
populations of lymphocytes. Indeed,
ALS has been shown to destroy circulating
T lymphocytes, leaving unharmed short-
lived, rapidly turned-over T cells resident
within the spleen and lymph nodes
(Lance, Medawar and Taub, 1973; Araneo,
Marrack and Kappler, 1975). Both thy-
mectomized, irradiated and reconstituted
(Woodruff et al., 1973; Gillette and Fox,
1975) and nude mice (Raff, 1973) possess
some T cells, and thymectomy alone has
been reported to deplete only short-lived
T cells (Kappler et al., 1974). Such
observations support the contention that
ALS destroys tumour-enhancing lympho-
cytes.
C. parvum had no antimetastatic
activity in mice that had received ALS.
Recent work by Christie and Bomford
(1975) has shown that peritoneal macro-
phages from untreated mice cannot be
activated in vitro by C. parvum alone
but only when C. parvum is added with
0-sensitive immune spleen cells. This
suggests that the action of C. parvum on
metastases is dependent upon a specific
population of long-lived circulating T
cells.
The abrogation of the antimetastatic
effects of C. parvum by ALS might also
be explained if this serum had an effect
on macrophages. ALS has been shown
to affect macrophage activity in vitro
(Hughes et al., 1971; Jakobsen, 1973)
but when we determined the activity
in vivo (by clearance of carbon) it did not
differ significantly in mice treated with
ALS from controls given NRS.
There is considerable evidence that
macrophages are involved in the anti-
tumour action of C. parvum (Ghaffar
et al., 1975; Christie and Bomford, 1975).
Therefore, we postulate that the
mechanism of inhibition of metastases
after i.v. administration of C. parvum
involves the activation of macrophages
in vivo through a specific subpopulation
of T cells (or their products) present in
thymectomized and irradiated but not
ALS-treated mice. Further studies are
being undertaken to determine the par-
ticular population of T cells involved.
The authors would like to thank
P. D. E. Jones for the carbon clearance
studies. Thisinvestigation wassupported
by the Cancer Research Campaign.
REFERENCES
ARANEO, B. A., MARRACK, P. C. & KAPPLER, J. W.
(1975) Functional Heterogenicity among the
Thymus-derived Lymphocytes of the Mouse: II
Sensitivity of Subpopulations to Antithymocyte
Serum. J. Imnmunol., 114, 747.
Biozzi, G., BENACERRAF, B., STIFFEL, C. &
HALPERN, B. N. (1954) Etude Quantitative du
l'Activit6 Granulopexique du Systeme R6ticulo-
endoth6lial chez la Souris. C. R. Soc. Biol.
Paris, 148, 431.
BOYLE, M. D. P., OHANIAN, S. H. & BORSOS, T.
(1976) Lysis of Tumour Cells by Antibody and
Complement. VI. Enhanced Killing of Enzyme-
pretreated Tumour Cells. J. Immunol., 116,
661.
CARNAUD, C., HOCH, B. & TRAININ, N. (1974)
Influence of Immunologic Competence of the
Host on Metastases Induced by the 3LL Lewis
Tumour in Mice. J. natn. Cancer Inst., 52, 395.
CASTRO, J. E. (1974) Surgical Procedures in Small
Laboratory Animals. J. Immunol. Meth., 4, 213.
CHRISTIE, G. H. & BOMFORD, R. (1975) Mechanisms
of Macrophage Activiation by (CorynebacteriumABROGATION OF ACTIVITY OF C. PARVUM BY ALS 295
parvurn: I. In vitro Experiments. Cell. Immunol.,
17, 141.
COURTENAY, V. D. (1976) A Soft Agar Colony Assay
for Lewis Lung Tumour and the B16 Mela-
noma Taken Directly from the Mouse. Br. J.
Cancer, 34, 39.
DAVIES, A. J. S., LEUCHARS, E., WALLIS, V. &
KOLLER, P. C. (1966) The Mitotic Response of
Thymus-derived Cells to Antigenic Stimulus.
Transplantation, 4, 438.
GHAFFAR, A., CULLEN, R. T. & WOODRUFF, M. F. A.
(1975) Further Analysis of the Antitumour
Effect in vitro of Peritoneal Exudate Cells from
Mice treated with Corynebacteriumn parvum.
Cancer, N.Y., 31, 15.
GILLETTE, R. W. & Fox, A. (1975) The Effect of
T Lymphocyte Deficiency on Tumour Induction
and Growth. Cell. Immunol., 19, 328.
HUGHES, D., NEWMAN, J. E. FIELD, E. J. &
WOODRUFF, M. F. A. (1971) Lack of Anti-
macrophage Species Specificity in ALS. Nature
New Biol., 230, 211.
JAKOBSEN, A. (1973) Rabbit Anti-rat Lymphocyte
Serum: in Vitro Antimacrophage Activity of
Different Types of Antisera and Relationship to
Immunosuppression. Acta path. microbiol.
scand., Sect. B, 81, 353.
JAMES, S. E. & SALSBURY, A. J. (1974) Effect of
(± )-1, 2-Bis (3,5-dioxopiperazin-1-yl) propane
on Tumour Blood Vessels and its Relationship
to the Antimetastatic Effect in the Lewis Lung
Carcinoma. Cancer Res., 34, 839.
KAPPLER, J. W., HUNTER, P. C., JACOBS, D. &
LORD, E. (1974) Functional Heterogenicity
among the Thymus-derived Lymphocytes of the
Mouse: I Analysis by Adult Thymectomy.
J. Immunol., 113, 27.
LANCE, E. M., MEDAWAR, P. B. & TAUB, R. N.
(1973) Antilymphocyte Serum. Advances IMM'nu-
nol., 17, 1.
OLIVOTTO, M. & BOMFORD, R. (1974) In Vitro
Inhibition of Tumour Cell Growth and DNA
Synthesis by Peritoneal and Lung Macrophages
from Mice injected with Corynebacteriumn parvum.
Int. J. Cancer, 13, 478.
PROCTOR, J., RUDENSTAM, C. M. & ALEXANDER, P.
(1973) Increased Incidence of Lung Metastases
following Treatment of Rats bearing Hepatomas
with Irradiated Tumour Cells and the Beneficial
Effect of Corynebacterium parvum in this System.
Biomed., 19, 248.
RAFF, M. C. (1973) 0-bearing Lymphocytes in Nuce
Mice. Nature, 246, 350.
SADLER, T. E. & CASTRO, J. E. (1976) The Effects
of Corynebacterium parvum and Surgery on the
Lewis Lung Carcinoma and its Metastases. Br.
J.Surg., 63, 292.
SCOTT, M. T. (1974) Corynebacterium parvum as a
Therapeutic Agent in Mice: II. Local Injection.
J. natn. Cancer Inst., 53, 861.
SIMPSoN-HERREN, L., SANFORD, A. H. & HoLMQuIsT,
J. P. (1974) Cell Population Kinetics of Trans-
planted and Metastatic Lewis Lung Carcinoma.
Cell. Tiss. Kinet., 7, 349.
SUGIURA, K. & STOCK, C. C. (1955) Studies in a
Tumour Spectrum: III. The Effect of Phosphora-
mides on the Growth of a Variety of Mouse and
Rat Tumours. Cancer Res., 15, 38.
TREVES, A. J., CARNAUD, C., TRAININ, N., FELDMAN,
M. & COHEN, I. R. (1974) Enhancing T Lympho-
cytes from Tumour-bearing Mice Suppress Host
Resistance to a Syngeneic Tumour. Eur. J.
Immunol., 4, 722.
UMIEL, T. & TRAINING, N. (1974) Immunological
Enhancement of Tumour Growth by Syngeneic
Thymus-derived Lymphocytes. Transplantation,
18, 244.
WEXLER, H. (1966) Accurate Identification of
Experimental Pulmonary Metastases. J. natn.
Cancer Inst., 36, 641.
WOODRUFF, M. F. A. & BOAK, J. L. (1966) Inhibitory
Effect of Injection of Corynebacterium parvum on
the Growth of Tumour Transplants in Isogenic
Hosts. Br. J. Cancer, 20, 345.
WOODRUFF, M. F. A. & DUNBAR, N. (1975) Effect
of Local Injection of Corynebacterium parvum on
the Growth of a Murine Fibrosarcoma. Br. J.
Cancer, 32, 34.
WOODRUFF, M. F. A., DUNBAR, N. & GHAFFAR, A.
(1973) The Growth of Tumours in T-cell Deprived
Mice and their Response to Treatment with
Corynebacterium parvum. Proc. B. Soc., B., 184,
97.